AllStripes Stock
Healthcare technology company
Sign up today and learn more about AllStripes Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About AllStripes Stock
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes develops a platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that enables patients to participate in treatment research online and benefit from their own medical data.
Investors
Spark Capital
Slack, Affirm, MessageBird, Discord, Anduril Industries, Rapyd, Plaid, Cybereason, Plume Design, Deel
Village Global
McKesson Ventures
Medidata Solutions
Jazz Venture Partners
Pear Therapeutics, Akili Interactive Labs, Pymetrics, AllStripes, Halo Neuroscience
Funding History
May 2018 | $120K |
---|---|
May 2018 | $3.0M |
January 2020 | $8.3M |
April 2020 | $100K |
April 2020 | $5.9M |
July 2021 | $50.3M |
Management
Chief Executive Officer
Nancy Yu
Chief Legal Officer
Sherwin Chen
Press
fiercebiotech - Aug, 24 2021
Rare disease data-focused AllStripes raises $50M to enhance medical record miningfinsmes - Aug, 24 2021
AllStripes Raises $50M in Series B Financingendpts - Apr, 17 2020
Abundant funding, sparse data: San Francisco startup backs 'real world' model for rare disease drug developmentxconomy - Aug, 20 2018
Rare-Disease Hackathon Leads to $3M for Health Data Startup RDMD